What is CVE-2023-27875?

CVE-2023-27875 is a high-severity vulnerability in IBM Aspera Faspex, classified under Improper Access Control. CVSS score: 7.5/10. Published 2023-03-16.

How severe is CVE-2023-27875?

High severity. CVSS v3 base score is 7.5 out of 10.

Vulnerability in IBM Aspera Faspex

CVE-2023-27875

IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM X-Force ID: 249847.

Published 2023-03-16 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N.

EPSS exploit prediction

EPSS: 0.006 (45.3th percentile), scored 2026-10-19.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 45th percentile — 45.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: 0.000

Affected products

Weakness classification (CWE)

CWE-284 — Improper Access Control

References

www.ibm.com/support/pages/node/6963662 (vendor-advisory, Patch, Vendor Advisory)
exchange.xforce.ibmcloud.com/vulnerabilities/249847 (VDB Entry, vdb-entry, Vendor Advisory)

Frequently asked questions

What is CVE-2023-27875?: CVE-2023-27875 is a high-severity vulnerability in IBM Aspera Faspex, classified under Improper Access Control. CVSS score: 7.5/10. Published 2023-03-16.
How severe is CVE-2023-27875?: High severity. CVSS v3 base score is 7.5 out of 10.